⏳ Fetching live dividend data...
Home › Calculator › ABIO Dividend Calculator 2026
ARCA biopharma, Inc. · NASDAQ
Price: $28.80 · Annual div: $1.61/share · Frequency: quarterly · Payout ratio: N/A · Ex-div: 2024-08-29
ABIO (ARCA biopharma, Inc.) has a dividend yield of 5.60%, based on an annual dividend of $1.61 per share and a price of $28.80. Over the last 12 months it paid $0.0000 per share — a trailing yield of 0.00%.
With dividends reinvested, a ABIO position grows its share count by about 5.60% in the first year at today's price and yield. If the yield stays near 5.60%, DRIP doubles your number of shares in about 13 years without adding new money.
| Year | Shares bought by dividends |
|---|
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
| Ex-Dividend Date | Payment Date | Amount / Share | TTM Yield | Stock Price |
|---|---|---|---|---|
| 2024-08-29Latest | — | $1.6130 | 4.54% | $35.52 |
ARCA biopharma, Inc. operates as a clinical-stage biopharmaceutical company dedicated to the creation and commercialization of genetically targeted therapies designed to address various cardiovascular ailments. The company's leading therapeutic programs feature two key candidates: Recombinant Nematode Anticoagulant Protein c2 (rNAPc2), known as AB201, which is currently being evaluated in a Phase IIb clinical trial for its potential in treating COVID-19. Gencaro (bucindolol hydrochloride), a distinctive pharmacogenetically-targeted beta-adrenergic receptor antagonist. This compound has already concluded its Phase IIb trial, demonstrating efficacy for the management of atrial fibrillation in patients afflicted with chronic heart failure. To further its research and development efforts, ARCA biopharma has established strategic collaborations. These include a partnership with LabCorp aimed at developing a genetic test for the GENETIC-AF clinical trial, as well as a research alliance with the Colorado Prevention Center (an academic research organization of the University of Colorado) focused on advancing and commercializing Gencaro. Founded in 2004, the company is based in Westminster, Colorado.
ABIO (ARCA biopharma, Inc.) has a dividend yield of 5.60%, based on an annual dividend of $1.61 per share and a price of $28.80. Over the last 12 months it paid $0.0000 per share — a trailing yield of 0.00%.
$10,000 in ABIO at a 5.60% yield pays about $560 a year ($47 a month) before taxes. With DRIP, reinvested dividends buy more shares and that income compounds.
With dividends reinvested, a ABIO position grows its share count by about 5.60% in the first year at today's price and yield. If the yield stays near 5.60%, DRIP doubles your number of shares in about 13 years without adding new money.
Enter your starting amount, monthly contribution and time horizon in the ABIO DRIP calculator at the top of this page. It reinvests each payout into new shares at the projected price, grows the dividend at the rate you choose and shows yearly income, share count, portfolio value and yield on cost. You can switch DRIP off to compare.
ABIO's next ex-dividend date has not been announced yet; the most recent one was 2024-08-29. Buy before the ex-dividend date to receive the next payment.
ABIO has less than a year of dividend history in our data, so there is no dividend growth rate yet.
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open ABIO position with:
Real after-tax yield depends on where you live and how you hold ABIO.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 5.60% | 2.80% | $560 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 4.76% | 1.96% | $476 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 4.48% | 1.68% | $448 / yr |
| 🇬🇧 UK ISA | 0% | 5.60% | 2.80% | $560 / yr |
| 🇬🇧 UK Taxable | 8.75% | 5.11% | 2.31% | $511 / yr |
| 🇨🇦 TFSA | 0% | 5.60% | 2.80% | $560 / yr |
| 🇨🇦 CA Taxable | 25% | 4.20% | 1.40% | $420 / yr |
| 🇦🇺 Super (pension) | 15% | 4.76% | 1.96% | $476 / yr |
| 🇦🇺 AU Taxable | 30% | 3.92% | 1.12% | $392 / yr |
| 🇩🇪 DE Taxable | 26.375% | 4.12% | 1.32% | $412 / yr |
| 🇫🇷 FR Taxable | 30% | 3.92% | 1.12% | $392 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $1.61/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
ABIO pays quarterly — 4 times per year. Ex-div: 2024-08-29.
How ABIO compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for ABIO sourced from FMP /financial-growth endpoint — real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| J-Other | 2024-08-29 | 6,000 | $2.32 | $13.9K | ||
| J-Other | 2024-08-29 | 12,000 | $2.27 | $27.2K | ||
| J-Other | 2024-08-29 | 6,000 | $1.64 | $9.8K | ||
| Buy | 2024-08-16 | 428 | $2.98 | $1.3K | ||
| Buy | 2024-08-16 | 5,390 | $2.93 | $15.8K | ||
| Buy | 2024-07-25 | 30,227 | $3.05 | $92.3K | ||
| Buy | 2024-07-24 | 7,056 | $3.16 | $22.3K | ||
| Buy | 2024-07-24 | 17,800 | $3.18 | $56.6K | ||
| Buy | 2024-07-24 | 165,000 | $3.20 | $528.0K | ||
| Buy | 2024-07-11 | 94,537 | $3.45 | $326.3K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Compare ABIO with peers: ABIO vs ANGN · ABIO vs CERC · ABIO vs EYEN
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the ABIO dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
ARCA biopharma, Inc. (ABIO) is currently trading at $28.80, 47% below its 52-week high. The current dividend yield is 5.60% based on an annual payout of $1.61 per share.
ARCA biopharma, Inc. (ABIO) is a healthcare stock currently trading at $28.80 with a dividend yield of 5.60%. It pays an annual dividend of $1.61 per share.
Auto-generated from live market data. For educational purposes only — not financial advice.
Illustrative examples of common use cases, written by the DividendFlow team — not customer reviews.
| Total shares |
|---|
| Dividend income |
|---|
| Position value |
|---|
| Yield on cost |
|---|
| 1 | 19.45 | 366.67 | $560 | $10,560 | 5.60% |
| 3 | 21.69 | 408.89 | $625 | $11,776 | 6.25% |
| 5 | 24.18 | 455.98 | $696 | $13,132 | 6.96% |
| 10 | 31.76 | 598.79 | $915 | $17,245 | 9.15% |
| 20 | 54.77 | 1032.63 | $1,577 | $29,740 | 15.77% |
DRIP rate = share-count growth from reinvested dividends. Simplified yearly model before taxes and fees; adjust every assumption in the calculator above. Not financial advice. How DRIP and the DRIP rate work →
Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.
I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.
Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.
As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.
The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.
For educational purposes only. Not financial advice.
Share your real experience on Trustpilot →If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
⏱️ Takes 30 seconds · No signup · Free forever